NORTH CHICAGO, Ill., June 6, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV ) today launched the AbbVie Migraine Career Catalyst Award TM, a first-of-its-kind contest designed to support the career, workplace, and professional development aspirations of people living with migraine. With more than 113 million workdays lost in the U.S. each year to the disease and its symptoms, migraine can have a major impact in the workplace. 1 Twenty contest entrants will win up to $2,500 that they can decide to use toward career support, including career counseling, professional development programs, and networking opportunities.